Stock Learning

Storage Experts to Discuss Challenges and Solutions for High-Throughput Sequencing and Next-Generation Cloud Storage Initiatives

CAMBRIDGE, UK--(Marketwire - March 10, 2010) -  CambridgeSoft today announces that VIB, a Belgium based non-profit life sciences research institute, has selected CambridgeSoft's E-Notebook for deployment to over 400 VIB researchers. This decision follows a successful pilot study carried out in 2009. E-Notebook, an application which facilitates research collaboration and knowledge management, will be rolled out during 2010 to VIB scientists active in many biotechnology research domains (genomics, plant biology, neurobiology, microbiology, etc) at four different universities in Flanders. 

ANN ARBOR, MI--(Marketwire - March 10, 2010) -  MichBio, the association for Michigan biosciences, will for the first time host its Annual Business Meeting and Showcase in Grand Rapids. The event will be held at Grand Valley State University's Eberhard Center on April 21 and feature a strolling dinner amid bioscience-related company exhibits from 5-7 p.m., followed by a keynote address by Mark B. Leahey, president and CEO of the Medical Device Manufacturers Association. The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC, that represents research-driven medical technology companies.

JOHANNESBURG, SOUTH AFRICA--(Marketwire - March 10, 2010) -  www.rothmanresearch.com

MOUNTAINSIDE, NJ--(Marketwire - March 10, 2010) -  Proteonomix, Inc. (PINKSHEETS: PROT) announces that its wholly-owned subsidiary, Proteonomix Regenerative Translational Medicine Institute, Inc. ("PRTMI"), has created a subsidiary, PRTMI RD S.R.L., a corporation organized under the laws of the Dominican Republic ("DR").

REHOVOT, ISRAEL--(Marketwire - March 10, 2010) - Evogene Ltd. (TASE: EVGN) announced today its financial results for the fourth quarter and year ended December 31, 2009.

PHILADELPHIA, PA--(Marketwire - March 10, 2010) -  Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Barclays Capital 2010 Global Healthcare Conference. Gearóid Faherty, Eurand's Chairman and Chief Executive Officer, will be presenting.

Agreement Aligns AspenBio With a Leading OEM Provider of Lateral Flow Assays and Completes the Supply Chain for Commercial Production of the AppyScore(TM) Test

Australian Patent Provides Broad Protection of its Small Molecule Drug Candidates

Dr. Bogin Is an Expert in Stem Cell Clinical Trials and the CEO of Cromos Pharma LLC; Company Sees Addition Aiding Clinical Trials Development for COPD Stem Cell Treatment Model

SOUTH SAN FRANCISCO, CA--(Marketwire - March 10, 2010) - Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that its fast skeletal muscle troponin activator, CK-2017357, has been granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig's Disease. CK-2017357 is the lead drug candidate that has emerged from the company's skeletal sarcomere activator program. Cytokinetics plans to initiate a Phase II Evidence of Effect clinical trial for CK-2017357 in ALS patients in the first half of 2010.

CHERRY HILL, NJ--(Marketwire - March 9, 2010) -  The Multiple Sclerosis Association of America (MSAA) encourages everyone to take time this March to learn about multiple sclerosis (MS) and discover all of the programs and services MSAA offers to everyone affected by MS.

FAIRFIELD, CA--(Marketwire - March 9, 2010) -  ChemSW, Inc. today announced the release of a new in-depth white paper that examines best practices for effectively controlling and reporting chemical inventory. Titled "How to Gain Complete Control of Your Chemical Inventory," the white paper provides tips and techniques for ensuring that chemical inventory is managed in a safe, efficient and cost-effective manner.

MANASSAS, VA--(Marketwire - March 9, 2010) -  Emerging World Pharma Inc. (PINKSHEETS: EWPI), an investor in generic based pharmaceutical companies manufacturing within developing nations, has provided an initial investment into a private generic pharmaceutical company located in West Africa. The investment would entitle Emerging World Pharma a percentage of profits obtained from an exclusive marketing and distribution agreement of generic pharmaceuticals. In addition the company has negotiated an option that would considerably increase the percentage of returns on profit with ongoing investments.

Nearly 200 Attendees and 40 Innovative Presenting Companies Along With a Dozen Sponsors Convened Last Week in Las Vegas

WEST PALM BEACH, FL--(Marketwire - March 9, 2010) - HearUSA, Inc. (NYSE Amex: EAR), a leader among the nation's hearing care providers, has been invited to present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference to be held at The Ritz Carlton in Dana Point, CA on March 15-17, 2010.

Objectif : amasser 50 000 $ pour les athlètes paralympiques du Canada en mars 2010

Largest Promotion in Company's History Yields Bonuses Exceeding 250,000 USD

Sets goal to raise $50,000 for Paralympians this March 2010

JERSEY CITY, NJ--(Marketwire - March 9, 2010) -  QUMAS, the leading provider of Compliance Solutions to highly regulated companies, has won the Deloitte Best Managed Companies Award.

BUFFALO, NY--(Marketwire - March 9, 2010) -  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Roth Capital Partners 22^nd Annual OC Growth Stock Conference, March 15-17, in Laguna Niguel, CA.

FORT LAUDERDALE, FL--(Marketwire - March 9, 2010) - OmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions, announced today that a leading cardiovascular medical device manufacturer has renewed its contract with the company for another 5 years. The agreement extends and expands the previous five-year agreement which generated over $2.5 Million in revenue for the company over the past three years. The company expects revenue for this customer to increase.

Ingeniux Will Power Over 30 Global Websites and Automate Compliance Safeguards

Scientific Bio-Logics Welcomes iogen

SEATTLE, WA--(Marketwire - March 9, 2010) - HQ Sustainable Maritime Industries, Inc. (NYSE Amex: HQS) ("HQS" or the "Company"), a leading producer of functional, sustainable Tilapia biomass, including fish and personal healthcare products, will announce results for the fourth quarter ended December 31, 2009 on Monday, March 15, 2010, after market close. The Company will also host a conference call to discuss these results with additional comments and details. Participating on the call will be Norbert Sporns, President and Chief Executive Officer, and Jean-Pierre Dallaire, Chief Financial Officer.

ROCKVILLE, MD--(Marketwire - March 9, 2010) -  MarketResearch.com has announced the addition of GBI Research's new report "Stem Cell Research -- Market Trends, Investment Trends and Pipeline Analysis," to their collection of Stem Cell market reports. For more information, visit http://www.marketresearch.com/redirect.asp?progid=67618&productid=2584292.

Dramatic Performance and Usability Improvements Provide Access to Broader Range of Real World Behaviors

Two New Programs Unveiled to Help Patients "Give Back"

BOTHELL, WA--(Marketwire - March 9, 2010) -  AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, will report fourth quarter and full year 2009 financial results before the NASDAQ Global Market opens on Tuesday, March 16, 2010. Subsequently, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time), Dr. Leslie Hudson, AVI's President and Chief Executive Officer, and J. David Boyle II, AVI's Senior Vice President and Chief Financial Officer, will host a conference call to discuss the fourth quarter and full year 2009 financial results and to provide a corporate update.

Order Equips First Responders in Hollywood Entertainment Hub With Tools to Protect Community From Bioterrorism Attack

Palomar's Emphasis Will Be on Its Model 8000 Wire Bonder/Ball (Stud) Bumper's Versatility, With a Method That Enables Higher Density Packages

BURBANK, CA--(Marketwire - March 8, 2010) -  Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Wednesday, March 10, 2010 at 1:00pm PST, (4:00pm EST) the company's CEO, Mr. Dean Janes, will be hosting a conference call. To join the conference call, please call 1-888-732-6202 and enter passcode 745546 followed by the pound sign (#). You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation.

PALATINE, IL and BRISTOL, TN--(Marketwire - March 8, 2010) -   Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) today announced top-line results from Study AP-ADF-114 ("Study 114") titled "A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Relative Abuse Potential of Acurox^® (oxycodone HCl and niacin) Tablets in Non-Dependent Recreational Opioid Users." Study 114 top-line results demonstrate that two different potentially abused excess oral doses of Acurox^® Tablets are significantly disliked compared to equivalent excess oral doses of oxycodone HCl tablets alone (without niacin). All five co-primary endpoints comparing the like/dislike of excess doses of Acurox^® Tablets with the like/dislike of excess doses of oxycodone HCl tablets

NEW YORK, NY--(Marketwire - March 8, 2010) -  NewCardio, Inc. (OTCBB: NWCI) announced today that CEO, Dr. Branislav Vajdic, was interviewed on CorporateProfile.com.

SALT LAKE CITY, UT--(Marketwire - March 8, 2010) - El sábado 27 de febrero, uno de los terremotos más grandes en la historia azotó el país de Chile. El terremoto tuvo una magnitud de 8.8 en la escala de Richter y causó un tsunami que devastó las comunidades de la costa al sur de la capital de Santiago de Chile.

SALT LAKE CITY, UT--(Marketwire - March 8, 2010) -  On Saturday, February 27, one of the largest earthquakes in recent history hit the country of Chile. The quake measured 8.8 on the Richter scale and set off a tsunami that devastated coastal communities south of the capital, Santiago.

LONDON--(Marketwire - March 8, 2010) -

Smith and Nephew Continues to Deliver its Strategic Priorities

Company to introduce new and innovative products at the American
Academy of Orthopaedic Surgeons 2010 Annual Meeting in New Orleans

Representatives from across the business to attend

London, United Kingdom, March 8, 2010 - Smith & Nephew plc (LSE: SN,
NYSE: SNN), the global medical technology business, continues to
deliver on its strategic priorities by introducing new and innovative
products from its Orthopedics and Endoscopy business units at this
yearOs American Academy of Orthopaedic Surgeons ("AAOS") Annual
Meeting. Smith & Nephew's presence at this year's Annual Meeting will
feature the launch of several new products, as well as advances in
Smith & Nephew's current portfolio, and representatives from Smith &
Nephew Orthopaedic's medical education platform, KLEOS, will be on
hand. The combined success of Smith & Nephew's Orthopae					

The Nation's Largest Distributor of Critical-Care Biopharmaceuticals Announces Its Participation in National Patient Safety Awareness Week; the Company Will Launch a Multi-Faceted Campaign Aimed at Empowering Patients to Become Involved in Their Own Healthcare

SOUTH PLAINFIELD, NJ--(Marketwire - March 8, 2010) - GENEWIZ, Inc., a leading provider of DNA services, announced the expansion of its molecular biology portfolio with the addition of Gene Synthesis services. Gene synthesis provides researchers with a time- and cost-saving alternative to molecular cloning, DNA engineering, protein engineering and directed evolution for custom construct production.

BAGSVAERD, DENMARK--(Marketwire - March 8, 2010) -

Walk Now for Autism Speaks, April 24, Pasadena Rose Bowl

LEIDEN, NETHERLANDS--(Marketwire - March 8, 2010) -

DANVILLE, CA--(Marketwire - March 8, 2010) -  S3 Investment Company, Inc. (PINKSHEETS: SIVC) today announced that the company's Redwood Medical subsidiary, which distributes Western medical technologies and products into the China market, is currently working on additional State Food and Drug Administration (SFDA) approvals for the first product it has signed to distribute in China. 

World Glaucoma Week Raises Global Awareness of the Importance of Eye Health

BOTHELL, WA--(Marketwire - March 8, 2010) -  MDRNA, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that J. Michael French, MDRNA's President and Chief Executive Officer, will provide an overview of the Company and its progress in key programs at the following upcoming conferences:

HIGH SPRINGS, FL--(Marketwire - March 8, 2010) -  CTD Holdings, Inc. (OTCBB: CTDH) (FRANKFURT: CDJ) today announced its plans to move the company's Aquaplex® product line out of the CTD, Inc. division and into NanoSonic Products, Inc. (NSP). The decision was made as a result of a successful orphan drug application filing made to the U.S. Food and Drug Administration for Trappsol® CycloT (hydroxypropyl beta cyclodextrin) in the treatment of Niemann Pick Type C disease.

To Serve as Platform for Screening of Regenerative Photoceuticals

MALVERN, PA--(Marketwire - March 8, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that XIAFLEXT (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, is now available by prescription in the United States for the treatment of adult Dupuytren's contracture patients with a palpable cord.

SAN DIEGO, CA--(Marketwire - March 8, 2010) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 30^th Annual Health Care Conference on March 10, 2010.

GLOSTRUP, DENMARK--(Marketwire - March 8, 2010) -

Business Intelligence Firm Cutting Edge Information Investigates Vendor Management

WEST LAFAYETTE, IN--(Marketwire - March 5, 2010) -  Bioanalytical Systems, Inc. (NASDAQ: BASI) announced today that it received notification from the NASDAQ Listing Qualification Department on March 4, 2010 that it has failed to maintain at least a $1 minimum bid price for its common shares (the "Minimum Bid Requirement"), which is required for continued listing of the Company's common shares on the NASDAQ Capital Market.

MILAN--(Marketwire - March 5, 2010) -

Strategic Partnership and Investment Meeting Precedes 'Medical Device Investor Day' at Same Venue on April 28th

Conference Call Scheduled for Friday, March 5, 2010, at 10:30 a.m. Eastern Time

SALT LAKE CITY, UT--(Marketwire - March 5, 2010) - Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI) announced today that it has been notified by its Italian partner, Costruzione Strumenti Oftalmici (CSO), that all necessary documents have been completed and submitted to the United States Food and Drug Administration (FDA) for the RetimaxT, also known as the Paramax. Paradigm is the exclusive representative for this significant new product in the U.S. market. "This new innovative device offers the earliest detection of glaucoma currently available and will be an excellent addition to Paradigm's glaucoma diagnostic products," said Stephen Davis, Paradigm's President and Chief Executive Officer.

SAN CLEMENTE, CA--(Marketwire - March 5, 2010) -  Micro Imaging Technology, Inc. (OTCBB: MMTC) announced that it has changed its company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software. The company currently produces the MIT 1000 Rapid Microbial Identification (ID) System that can identify bacteria in less than five minutes with a laser that uses the principles of light scattering and with proprietary PC-based software algorithms to test bacteria samples at less than $0.10 per test.

BRISTOL, TN--(Marketwire - March 4, 2010) -  King Pharmaceuticals, Inc. (NYSE: KG) today announced plans to provide a live webcast of its presentation scheduled for Wednesday, March 10, 2010, at 10:15 a.m. ET, at the Cowen & Co. 30^th Annual Healthcare Conference at the Marriott Copley Place Hotel in Boston, Massachusetts. The presentation may include a discussion of the Company's marketed products, pipeline, strategy for growth, financial results and expectations, and other matters relating to its business.

The PSA Test Could Not and Cannot Do What It Has Been Purported to Do for Screening for Prostate Cancer, According to Dr. Richard J. Ablin (Robert Benjamin Ablin Foundation for Cancer Research)

NEW YORK, NY--(Marketwire - March 4, 2010) - While clinical laboratories are vital to the diagnostic industry, they are facing multiple challenges that will require increased automation in order for them to remain competitive. But they must not go about the process of implementation haphazardly without a proper work flow analysis, or they may see no real improvements, according to healthcare market research publisher Kalorama Information's "Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends)." The report forecasts $5.35 billion in sales of clinical lab automation hardware and software in 2010, with growth through 2014 estimated at about 7%.

Intas Pharmaceutical to Launch Phase 3 Clinical Trial in India to Test Amarillo Biosciences' Oral Interferon Against Influenza

COLUMBIA, SC--(Marketwire - March 4, 2010) -  BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, will continue accepting pre book orders for the 2010 - 2011 flu season, as recent recommendations provided by the FDA's Vaccines and Related Biological Products Advisory Committee suggest that manufacturers include the H1N1 strain in the upcoming seasonal flu vaccine. Due to these recommendations, BDI anticipates an uptake in pre book orders.

DEERFIELD, IL--(Marketwire - March 4, 2010) - Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEXT (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANTT (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

LEXINGTON, MA--(Marketwire - March 4, 2010) -  Inotek Pharmaceuticals Corp., a clinical-stage drug development company advancing innovative drug candidates to address significant eye disease, with a major focus on glaucoma, today announced that Paul G. Howes, President and CEO, will present a corporate overview at the Cowen and Company 30th Annual Health Care Conference on Thursday March 11, 2010 at 9:30 a.m. Eastern Time. The conference will be held at the Boston Marriott Copley Place Hotel, Boston, MA.

New 24 Hour Location Opens on 16th Street and 8th Avenue

Company Honors Winners of Essay Contest for Their Contributions to Better Dentistry

BUFFALO, NY--(Marketwire - March 4, 2010) -  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company will hold its 2010 annual stockholders meeting on June 8, 2010 in Buffalo, NY for stockholders of record as of April 9, 2010. The Company will distribute proxy materials to all eligible stockholders.

FORT LAUDERDALE, FL--(Marketwire - March 4, 2010) -   OmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions announced that it released TrialOne, a fully integrated, MS .NET, web-based solution designed to automate the Phase I Clinical Trial Process. TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and address the unique requirements of early phase studies. Within each study, real-time electronic data is captured and validated directly at the subject's bedside or at a subject queuing station. Enhanced workflow technology automates sample processing throughout the lab. TrialOne supports a myriad of directly attached biomedical monitoring devices such as the GE Healthcare DINAMAP® family of vital signs monitors and various ECG devi

Symbollon Initiates Sales of iogen Through Web Site buyiogen.com

Company to Continue Developmental Work on Idiopathic Pulmonary Fibrosis in Conjunction With the University of Rochester

Audience Grew 93% in 2009 as Niche Health Sites Attracted Greater Audience; Advertising Rose 56% in Q409, Fueled by Deals With Wal-Mart Pharmacy, Shire, J&J and Merck

MALVERN, PA--(Marketwire - March 4, 2010) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Cowen and Co. 30th Annual Health Care Conference to be held March 8 - 11, 2010 at The Boston Marriott Copley Place. Mr. Jim Fickenscher, Chief Financial Officer, is scheduled to present an overview of the Company and its product pipeline at 10:20a.m. ET on Thursday, March 11, 2010.

AMSTERDAM, THE NETHERLANDS--(Marketwire - March 4, 2010) - Eurand N.V. (NASDAQ: EURX)

SAINT LAURENT, QUEBEC AND TORONTO, ONTARIO--(Marketwire - March 4, 2010) - IntelGenx Corp. (TSX VENTURE:IGX) (OTCBB:IGXT) and Cannasat Therapeutics Inc. (TSX VENTURE:CTH) announced today that they have entered into a Letter of Intent ("LOI"). Under the terms of the LOI, IntelGenx would acquire a fifty percent ownership stake from Cannasat and an exclusive worldwide license to develop and commercialize Relivar, a novel formulation of dronabinol, utilizing IntelGenx's proprietary mucoadhesive AdVersa technology, for the treatment of various diseases including neuropathic pain.

Retinal Degenerative Research Experts Will Gather With Drug and Device Developers, to Speed Development of Important New Modalities; Event Co-Chaired by Versant Ventures Managing Director, William J. Link, Ph.D., and Internationally Recognized Retinal UCI Specialist Dr. Baruch Kuppermann

NEW YORK, NY--(Marketwire - March 3, 2010) -  News reports coming out of the UK and Australia show evidence of prescription ingredients in many "natural" herb remedies sold on the Internet to treat erectile dysfunction (ED). These popular online supplements, which claim to consist only of homeopathic ingredients, are often improperly labeled and may actually contain dangerous ingredients. Dr. J. Francois Eid, director and founder of Advanced Urological Care in New York City, is concerned about this practice, especially since, in his experience, men with erectile dysfunction choose to suffer in silence rather than seek medical help for their condition.

CALGARY, ALBERTA--(Marketwire - March 3, 2010) - FoodChek Systems Inc. ("FoodChek") (anteriormente Vacci-Test Corporation) se complace en anunciar que el AOAC Research Institute (Instituto de Investigación de la Asociación de Químicos Analíticos Oficiales), el organismo de aprobación para todas las pruebas de seguridad de alimentos de Estados Unidos, aprobó una modificación a su prueba existente FoodChek(TM)-E. coli O157 de una muestra de 25g al tamaño de muestra estándar en la industria de 375g para la detección de E. coli O157 en la carne molida cruda. Esta extensión de aprobación de la AOAC también incluye los tamaños de muestras de compuestos de 65g y 325g.

NEW YORK, NY--(Marketwire - March 3, 2010) -  With more and more high profile celebrities being diagnosed with the "silent killer" known as prostate cancer (most recently the actor Louis Gossett Jr.), Dr. David B. Samadi, Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center, believes this is a good time to advise the public on the facts of prostate cancer.

MONTREAL, CANADA--(Marketwire - 3 mars 2010) - Laboratoires Paladin Inc. (TSX:PLB), chef de file de l'industrie pharmaceutique spécialisée au Canada, a annoncé aujourd'hui son investissement stratégique dans la société SpePharm Holding B.V. SpePharm est une société pharmaceutique spécialisée qui connaît une croissance rapide et qui concentre ses efforts sur l'acquisition, l'obtention de droits de distribution sous licence et la commercialisation de médicaments spécialisés à valeur médicale élevée partout en Europe.

MONTREAL, CANADA--(Marketwire - March 3, 2010) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that it has made a strategic investment in SpePharm Holding B.V. SpePharm is a rapidly-growing, specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines throughout Europe. U

MORRISTOWN, NJ--(Marketwire - March 3, 2010) -  Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Cowen and Company 30^th Annual Healthcare Conference on Tuesday, March 9, 2010 at 11:05 am Eastern Standard Time at the Boston Marriott Copley Place.

DAVIS, CA--(Marketwire - March 3, 2010) -  AgraQuest Inc. today announced that it has significantly strengthened its financial standing by closing a transaction resulting in the conversion by Loudwater Trust Limited of its note with an original face value of $10 million, plus certain accrued interest, into AgraQuest preferred stock. Separately, AgraQuest announced that it has obtained a line of credit from Silicon Valley Bank to support working capital growth.

PALM BEACH GARDENS, FL--(Marketwire - March 3, 2010) -  AccuDial Pharmaceutical, Inc. announced today that their initial financing, a private placement for four million shares at $1 per share, has been successfully closed. This funding round was accomplished entirely by AccuDial's management team and board of directors without any institutional involvement.

Program Designed to Raise Awareness for DVT and Ways to Keep Your Body Active Everywhere

OnePointRx Provides Suite of Reports Customized to Meet the Unique Needs of Hospices

CALGARY, ALBERTA--(Marketwire - March 3, 2010) - A FoodChek Systems Inc. ("FoodChek") (ex-Vacci-Test Corporation) tem o prazer de anunciar que o AOAC Research Institute, a entidade de aprovação para todos os testes de segurança de alimentos nos EUA, aprovou uma modificação para o teste FoodChek(TM)-E. coli O157 para uma amostra de 25 g para o tamanho padrão do setor de 375 g para a detecção de E. coli O157 na carne moída crua. Esta extensão da aprovação do AOAC também inclui os tamanhos de amostras compostos de 65 g e de 325 g.

CLEVELAND, OH--(Marketwire - March 3, 2010) -  CareerBoard.com announced today the addition of SanFrancisco.CareerBoard.com to their online network of 47 local job boards. 

CLEVELAND, OH--(Marketwire - March 3, 2010) -  CareerBoard.com announced today the addition of Seattle.CareerBoard.com to their online network of 47 local job boards. 

Government EMR Incentive Raises PHR Visibility and Promotes Usage